Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of IN.PACT (Paclitaxel) Admiral Drug-Coated Balloon (DCB) vs. Standard Percutaneous Transluminal Angioplasty (PTA) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)

NCT01566461 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT01566461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01566461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of IN.PACT (Paclitaxel) Admiral Drug-Coated Balloon (DCB) vs. Standard Percutaneous Transluminal Angioplasty (PTA) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2018
Enrollment
331 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

femoral artery occlusion, femoral artery stenosis, popliteal artery occlusion, popliteal artery stenosis